Lecture 4 - Cell Signalling and Cancer Flashcards

1
Q

What is intracellular singalling?

A

a set of linked biochemical events that connect a specific biological stimulus with a specific cellular response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Communication between cells control….

A

cell behaviour

  • survival
  • division
  • differentiation
  • apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Signal molecules bind to specific receptors.

What are the two main types of receptor?

A

intracellular receptors e.g. steroid receptors

cell-surface receptors e.g. for insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe briefly the intracellular signal transduction pathway

A
  • extracellular signal molecule
  • receptor protein
  • intracellular signalling proteins
  • target proteins e.g. metabolic enzymes, gene regulatory protein, cytoskeletal protein
  • response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the tyrosine kinase receptors?

Describe their structure

A

Enzyme coupled receptors are an important class of cell surface receptor

  • Single pass membrane spanning protein
  • Variety of extracellular domains
  • Cytoplasmic TK domain –> phosphorylates tyrosine residues on target proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Give examples of some molecules that act through RTKs

A
EGF
IGF
NGF
MCSF
FGF
VEGF
Eprhins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which 2 important pathways are activated by signal molecules interacting with receptor tyrosine kinases?

A

MAP (mitogen activate protein) kinase pathway

PI-3-kinase pathway - phosphatidylinositol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Give the 9 simple steps of the MAP kinase pathway

A
signal molecule
receptor tyrosine kinase
Grb-2
Ras-GEF
Ras
MAP-kinase-kinase-kinase (Raf)
MAP-kinase-kinase (Mek)
MAP-kinase (Erk)
Cell growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Phosphorylation and dephosphorylation modifies the activity of many target proteins. How?

A

Protein kinases catalyse the transfer of the terminal phosphate group of ATP to specific Set, Thr, Tyr residues on target proteins.
Protein phosphatases dephosphyrlate proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe dimerisation and autophophorylation and their functions

A
  • Binding of the singnalling molecule induces receptor dimerisation
  • Enable kinase domains of neighbouring receptors to cross-phosphorylate each other on multiple Tyr residues (autophosphorylation)
  • Phosphorylation of Tyr residues creates high-affinity docking sites for a variety of proteins: Grb-2 (MAP kinase pathway) and PI 3-kinase (PI 3-kinase pathway)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is Grb-2?

What does it do?

A
  • Adaptor protein with SH2 domain which recognises specific phosphorylated Tyr residues on RTK
  • Grb-2 also contains SH3 domain which binds to a proline rich motif in a protein called Sos
  • Assembly of the receptor-Grb2-Sos complex enables Sos to recruit and activate Ras
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Ras?

Where is it found?

A
  • small protein with GTPase activity

- contains a covalently attached lipid group that attaches it to the plasma membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is Sos?

What does it do?

A

Sos is a guanine nucleotide exchange factor (GEF) which activates Ras by stimlulating it to exchange GDP for GTP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is Ras inactivated?

A

GTPase activating proteins (GAP) inactivate Ras by stimulating its intrinsic GTPase activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

one word answer:
What turns Ras on?
What turns Ras off?

A
on = Sos
off = GAP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does Ras do?

A

onward transmission of signal along multiple pathways

  • Ras is not a kinase but it activates Raf which is a kinase
  • Raf activates Mek
  • Mek activates Erk
17
Q

What are Raf, Mek and Erk examples of?

A

serine threonine kinases

18
Q

What is the role of Erk?

Where do it act?

A
  • Erk phosphorylates a variety of target proteins including other kinases and gene regulatory proteins in the NUCLEUS.
  • The resulting changes in protein activity and gene expression cause complex changes in cell behaviour including cell growth/proliferation
  • Genes activated include: c-jun, c-fos, c-myc, c-myb, cyclin D = all TF’s
19
Q

In what 4 ways can the signal from the MAP kinase pathway be turned off?

A
  • removal of extracellular signal
  • switching off activated receptor tyrosine kinases by protein tyrosine phosphatases e.g. SHP1 and SHP2
  • Ras GAPs
  • desphosphorylation of target proteins by serine/threonine phosphatases
20
Q

Why is tight regulatory of the MAP kinase pathway essential?

A
  • constitutive activation of a protein in the pathway as a result of gene mutation predisposes to cancer
  • many RTKs, Ras, jun, fos, myc etc are oncogenes
21
Q

Give the 7 steps of the PI-3-kinase pathway

A
  • signal molecule
  • receptor tyrosine kinase
  • PI-3-kinase
  • PI(3,4,5)P3
  • PDK1
  • Akt (PKB) –> cell survival
  • Akt (PKB) –> mTOR –> cell growth
22
Q

How is the PI-3-kinase enyzme activated?

What does it then do?

A

by binding to Try residues on RTK

- catalyses the phosphorylation of PIP2 to generate PIP3

23
Q

What is phosphatidylinositol?

Where is it found?

A
  • a phospholipid found in eukaryotic cell membranes

- it is phosphyralted to form PIP, which is phosphphorylated again to PIP2 which is activated by PI-3-kinase

24
Q

What happens down stream of PIP3?

A

PIP3 acts as a docking site for 2 proteins, PDK1 and Akt.

Upon binding PDK1 phosphorylates and activates Akt,

25
Q

How does Akt induced cell survival?

A
Active Akt (activated by PDK1) phosphorylates a variety of targets including the protein BAD.
Active BAD results in the release of death inhibitory proteins and the prevention of apoptosis
26
Q

How does Akt induced cell growth and cell survival?

via what kinase?

A

Akt interacts with mTOR (kinase)
mTOR complex 1: stimulates cell growth by promoting ribosome production and protein synthesis, and inhaling protein degradation
mTOR complex 2: stimulates cell survival (and cell growth) by helping to activate Akt

27
Q

In what 4 ways and the PI-3-kinase pathway be switched off?

A
  • removal of extracellular signal
  • switching off activated RTKs by protein tyrosine phosphatases
  • dephoshphorylation of target proteins by serine/threonine phosphatases
  • PTEN, an inositol lipid phosphatase which removes phosphate from PIP3, so that it not longer acts as a docking site for PDK1 and Akt
28
Q

What is stratified (personalised) medicine?

A

a more effective way of treating cancer by grouping people according to the genetic lesion within individuals, and then targeting that lesion or signalling pathway to which it contributes

29
Q

What are the two examples of personalised medicine from this lecture?

A

HER2 and Herceptin

BCR-ABL and Gleevec

30
Q

What family is HER2 a member of?
What is meant by it being an ‘orphan receptor’?
How is HER2 activated?
What happens if HER2 is over expressed?

A
  • epidermal growth factor family (EGFR)
  • it has no ligand
  • activated by heterodimerisation with other EGFR family members
  • over expression leads homodimerisation of HER2 –> constitutive signalling (in the absence of a ligand)
31
Q

How does HER2 status influence breast cancer survival?

A

HER2 positive –> 3 years

HER2 negative –> 6-7 years

32
Q

What is the medical management for HER2 positive patients?

A

Trastuzumab (Herceptin)
- humanised anti-HER antibody that causes HER2 internalisation/degradation or ADCC
-

33
Q

Explain BCR-ABL and chronic myeloid leukaemia

A
  • CML usually associated with the Philadelphia chromosome which forms as a result of a translocation between chromosomes 22 and 9
  • breakage and rejoining occurs at the sites of the BCR and ABL genes, creating a hybrid gene that encodes a hybrid BCR-ABL fusion protein
  • ABL is a a cytoplasmic Tyr kinase that promotes cell survival and cell growth
  • Substitution of the normal N-terminus of ABL with BCR, constituently activates ABL Tyr kinase activity
  • BCR-ABL stimulates inappropriate proliferation of haemopoetic precursor cells, and prevents them from dying from apoptosis
34
Q

What is the medical management for CML?

A

Imatinib (Gleevec)
- synthetic ABL kinase inhibitor that blocks the ATP binding pocket of the Tyrosine kinase domain of BCR-ABL (ABL can no longer phosphorylate proteins)